SEC Form 4 · accession 0001645627-19-000002
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jan 3, 2019
Accepted (ET)
Jan 9, 2019 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 3, 2019 | P | 2,000 | $0.0184 | A | 26,662,697 | D | |
| Common Stock | Jan 3, 2019 | P | 1,000 | $0.019 | A | 26,663,697 | D | |
| Common Stock | Jan 3, 2019 | P | 1,000 | $0.0189 | A | 26,664,697 | D | |
| Common Stock | Jan 3, 2019 | P | 2,000 | $0.0189 | A | 26,666,697 | D | |
| Common Stock | Jan 3, 2019 | P | 1,000 | $0.0187 | A | 26,667,697 | D | |
| Common Stock | Jan 4, 2019 | P | 1,000 | $0.0188 | A | 26,668,697 | D | |
| Common Stock | Jan 7, 2019 | P | 100 | $0.0193 | A | 26,668,797 | D | |
| Common Stock | Jan 9, 2019 | P | 100 | $0.0196 | A | 26,668,897 | D |
Table II — derivative securities
No Table II lines on this filing.